Ranjan Kumar Nanda

1.7k total citations
41 papers, 1.2k citations indexed

About

Ranjan Kumar Nanda is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Ranjan Kumar Nanda has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Ranjan Kumar Nanda's work include Tuberculosis Research and Epidemiology (6 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Mycobacterium research and diagnosis (5 papers). Ranjan Kumar Nanda is often cited by papers focused on Tuberculosis Research and Epidemiology (6 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Mycobacterium research and diagnosis (5 papers). Ranjan Kumar Nanda collaborates with scholars based in India, United States and Singapore. Ranjan Kumar Nanda's co-authors include Shneh Sethi, Trinad Chakraborty, Rintu Banerjee‬‬‬‬‬‬‬‬‬, Nilmoni Sarkar, M. Das, Rakesh Arya, Kishore Kumar Pasikanti, Rupak Singla, Virander S. Chauhan and Jayati Ray Dutta and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Chemistry and Clinical Microbiology Reviews.

In The Last Decade

Ranjan Kumar Nanda

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ranjan Kumar Nanda India 18 502 372 133 120 110 41 1.2k
Erika Roat Italy 19 754 1.5× 64 0.2× 89 0.7× 22 0.2× 133 1.2× 26 1.6k
Tushar Kanti Maiti India 22 877 1.7× 51 0.1× 100 0.8× 45 0.4× 188 1.7× 67 1.5k
Yin Kwan Wong China 20 676 1.3× 146 0.4× 221 1.7× 29 0.2× 158 1.4× 48 1.5k
Anis Ahmad United States 21 375 0.7× 77 0.2× 148 1.1× 22 0.2× 127 1.2× 58 1.6k
Amjad Khan United Kingdom 22 567 1.1× 168 0.5× 139 1.0× 82 0.7× 71 0.6× 72 1.5k
I Hayakawa Japan 25 650 1.3× 77 0.2× 142 1.1× 111 0.9× 96 0.9× 77 1.7k
Teruki Yoshimura Japan 22 460 0.9× 207 0.6× 83 0.6× 57 0.5× 129 1.2× 73 1.1k
Yew Mun Lee Singapore 20 825 1.6× 97 0.3× 164 1.2× 63 0.5× 197 1.8× 33 1.7k
S. K. Shrivastava India 20 560 1.1× 93 0.3× 194 1.5× 32 0.3× 33 0.3× 73 1.2k
Eleonora Turrini Italy 24 815 1.6× 211 0.6× 43 0.3× 17 0.1× 260 2.4× 62 2.0k

Countries citing papers authored by Ranjan Kumar Nanda

Since Specialization
Citations

This map shows the geographic impact of Ranjan Kumar Nanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranjan Kumar Nanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranjan Kumar Nanda more than expected).

Fields of papers citing papers by Ranjan Kumar Nanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranjan Kumar Nanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranjan Kumar Nanda. The network helps show where Ranjan Kumar Nanda may publish in the future.

Co-authorship network of co-authors of Ranjan Kumar Nanda

This figure shows the co-authorship network connecting the top 25 collaborators of Ranjan Kumar Nanda. A scholar is included among the top collaborators of Ranjan Kumar Nanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranjan Kumar Nanda. Ranjan Kumar Nanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nanda, Ranjan Kumar, et al.. (2025). Advances and challenges in immunotherapy in head and neck cancer. Frontiers in Immunology. 16. 1596583–1596583. 2 indexed citations
2.
Pal, Rahul, Taruna Sharma, Sonu Kumar Gupta, et al.. (2024). Rv0495c regulates redox homeostasis in Mycobacterium tuberculosis. Tuberculosis. 145. 102477–102477. 3 indexed citations
3.
Kumar, Shakti, Agila Kumari Pragasam, Jyoti Verma, et al.. (2023). Collinsella aerofaciens linked with increased ethanol production and liver inflammation contribute to the pathophysiology of NAFLD. iScience. 27(2). 108764–108764. 7 indexed citations
4.
Saha, Sourav, Ranjit Das, Amit Kumar Pandey, et al.. (2023). Low circulatory Fe and Se levels with a higher IL-6/IL-10 ratio provide nutritional immunity in tuberculosis. Frontiers in Immunology. 13. 985538–985538. 7 indexed citations
5.
Nanda, Ranjan Kumar, et al.. (2023). Ten years survival results of randomized study comparing weekly vs. triweekly cisplatin with concurrent radiation in locally advanced carcinoma cervix. Reports of Practical Oncology & Radiotherapy. 28(3). 322–331. 3 indexed citations
6.
Sen, Kaushik, et al.. (2022). NCoR1 controls immune tolerance in conventional dendritic cells by fine-tuning glycolysis and fatty acid oxidation. Redox Biology. 59. 102575–102575. 31 indexed citations
7.
Prakāsh, Chandra, et al.. (2022). Acute radiofrequency electromagnetic radiation exposure impairs neurogenesis and causes neuronal DNA damage in the young rat brain. NeuroToxicology. 94. 46–58. 11 indexed citations
8.
Sahu, Debasis, Md. Zubbair Malik, Shikha Sharma, et al.. (2022). Troxerutin-Mediated Complement Pathway Inhibition is a Disease-Modifying Treatment for Inflammatory Arthritis. Frontiers in Cell and Developmental Biology. 10. 845457–845457. 2 indexed citations
9.
Kumar, Ankit, Jitendra K. Thakur, Souvik Maiti, et al.. (2021). Zinc 2+ ion inhibits SARS-CoV-2 main protease and viral replication in vitro. Chemical Communications. 57(78). 10083–10086. 41 indexed citations
10.
Shriwas, Omprakash, Rakesh Arya, Sugandh Kumar, et al.. (2021). Correction: RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway. British Journal of Cancer. 124(12). 2039–2039. 1 indexed citations
11.
Nanda, Ranjan Kumar, et al.. (2021). Weekly vs. tri-weekly cisplatin based chemoradiation in carcinoma cervix: a prospective randomized study of toxicity and compliance. Reports of Practical Oncology & Radiotherapy. 26(6). 948–954. 6 indexed citations
12.
Shriwas, Omprakash, Arup Ghosh, Shuchi Smita, et al.. (2021). CMTM6 drives cisplatin resistance by regulating Wnt signaling through ENO-1/AKT/GSK3β axis. JCI Insight. 6(4). 41 indexed citations
13.
Ghosh, Nilanjana, Priyanka Choudhury, Rakesh Arya, et al.. (2020). Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO). Respiratory Research. 21(1). 126–126. 43 indexed citations
14.
Kumar, Santosh, Ankur Kulshreshtha, Ranjan Kumar Nanda, et al.. (2019). The phytochemical bergenin as an adjunct immunotherapy for tuberculosis in mice. Journal of Biological Chemistry. 294(21). 8555–8563. 30 indexed citations
15.
Rahman, Md Rezanur, Tania Islam, Beste Turanlı, et al.. (2018). Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer’s disease. Computational Biology and Chemistry. 78. 431–439. 90 indexed citations
16.
Nanda, Ranjan Kumar, et al.. (2016). Hyperfractionated radiotherapy and concurrent chemotherapy in locally advanced hypopharyngeal cancers– an institutional experience. International Journal of Medical Research and Review. 4(6). 1017–1023. 1 indexed citations
17.
Meena, Ramovatar, et al.. (2016). Biofluid metabotyping of occupationally exposed subjects to air pollution demonstrates high oxidative stress and deregulated amino acid metabolism. Scientific Reports. 6(1). 35972–35972. 21 indexed citations
18.
Nanda, Ranjan Kumar, et al.. (2015). Prediction of outcome in buccal cancers treated with radical radiotherapy based on the early tumor response. Journal of Cancer Research and Therapeutics. 11(2). 364–364. 1 indexed citations
19.
Agrawal, Anurag, et al.. (2013). Lung cancer biomarkers: State of the art. Journal of Carcinogenesis. 12(1). 3–3. 67 indexed citations
20.
Ingenito, A, et al.. (1999). Potential Decreased Morbidity of Interstitial Brachytherapy for Gynecologic Malignancies Using Laparoscopy: A Pilot Study. Gynecologic Oncology. 73(2). 210–215. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erika Roat Breakdown of academic impact, for papers by Tushar Kanti Maiti Breakdown of academic impact, for papers by Yin Kwan Wong Breakdown of academic impact, for papers by Anis Ahmad Breakdown of academic impact, for papers by Amjad Khan Breakdown of academic impact, for papers by I Hayakawa Breakdown of academic impact, for papers by Teruki Yoshimura Breakdown of academic impact, for papers by Yew Mun Lee Breakdown of academic impact, for papers by S. K. Shrivastava Breakdown of academic impact, for papers by Eleonora Turrini
Rankless by CCL
2026